Literature DB >> 23929738

Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.

Seyed Ali Hosseini1, Susan Horton, Joshua C Saldivar, Satoshi Miuma, Martha R Stampfer, Nyla A Heerema, Kay Huebner.   

Abstract

Chromosomal positions of common fragile sites differ in lymphoblasts and fibroblasts, with positions dependent on the epigenetically determined density of replication origins at these loci. Because rearrangement of fragile loci and associated loss of fragile gene products are hallmarks of cancers, we aimed to map common fragile sites in epithelial cells, from which most cancers derive. Among the five most frequently activated sites in human epithelial cells were chromosome bands 2q33 and Xq22.1, which are not among top fragile sites identified in lymphoblasts or fibroblasts. FRA16D at 16q23 was among the top three fragile sites in the human epithelial cells examined, as it is in lymphoblasts and fibroblasts, while FRA3B at 3p14.2, the top fragile locus in lymphoblasts, was not fragile in most epithelial cell lines tested. Epithelial cells exhibited varying hierarchies of fragile sites; some frequent epithelial cell fragile sites are apparently not frequently altered in epithelial cancers and sites that are frequently deleted in epithelial cancers are not necessarily among the most fragile. Since we have reported that loss of expression of the FRA3B-encoded FHIT protein causes increased replication stress-induced DNA damage, we also examined the effect of FHIT-deficiency on markers of genome instability in epithelial cells. FHIT-deficient cells exhibited increases in fragile breaks and in γH2AX and 53BP1 foci in G1 phase cells, confirming in epithelial cells that the FHIT gene and encompassing FRA3B, is a "caretaker gene" necessary for maintenance of genome stability.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23929738      PMCID: PMC4293015          DOI: 10.1002/gcc.22097

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  51 in total

1.  Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells.

Authors:  E Sonoda; M S Sasaki; C Morrison; Y Yamaguchi-Iwai; M Takata; S Takeda
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 2.  Genetic polymorphisms and micronucleus formation: a review of the literature.

Authors:  G Iarmarcovai; S Bonassi; A Botta; R A Baan; T Orsière
Journal:  Mutat Res       Date:  2007-10-22       Impact factor: 2.433

3.  A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.

Authors:  J Chien; K Narita; R Rattan; S Giri; R Shridhar; J Staub; D Beleford; J Lai; L R Roberts; J Molina; S H Kaufmann; G C Prendergast; V Shridhar
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

4.  Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer.

Authors:  Beyhan Cengiz; Mehmet Gunduz; Hitoshi Nagatsuka; Levent Beder; Esra Gunduz; Ryo Tamamura; Naila Mahmut; Kunihiro Fukushima; Mahmoud Al Sheikh Ali; Yoshio Naomoto; Kenji Shimizu; Noriyuki Nagai
Journal:  Oral Oncol       Date:  2006-07-20       Impact factor: 5.337

5.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.

Authors:  Maria J Worsham; Gerard Pals; Jan P Schouten; Fred Miller; Nivedita Tiwari; Rosalina van Spaendonk; Sandra R Wolman
Journal:  Breast Cancer Res Treat       Date:  2006-03       Impact factor: 4.872

7.  Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case.

Authors:  Robert Finch; Harvey G Moore; Noralane Lindor; Syed M Jalal; Arnold Markowitz; Jhanwar Suresh; Kenneth Offit; Jose G Guillem
Journal:  Dis Colon Rectum       Date:  2005-11       Impact factor: 4.585

8.  Loss of FHIT function in lung cancer and preinvasive bronchial lesions.

Authors:  G Sozzi; U Pastorino; L Moiraghi; E Tagliabue; F Pezzella; C Ghirelli; S Tornielli; L Sard; K Huebner; M A Pierotti; C M Croce; S Pilotti
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

9.  NR2F1 deletion in a patient with a de novo paracentric inversion, inv(5)(q15q33.2), and syndromic deafness.

Authors:  Kerry K Brown; Fowzan S Alkuraya; Michael Matos; Richard L Robertson; Virginia E Kimonis; Cynthia C Morton
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

10.  RORA, a large common fragile site gene, is involved in cellular stress response.

Authors:  Y Zhu; S McAvoy; R Kuhn; D I Smith
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

View more
  30 in total

1.  Oncogenes create a unique landscape of fragile sites.

Authors:  Karin Miron; Tamar Golan-Lev; Raz Dvir; Eyal Ben-David; Batsheva Kerem
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

Review 2.  The role of fork stalling and DNA structures in causing chromosome fragility.

Authors:  Simran Kaushal; Catherine H Freudenreich
Journal:  Genes Chromosomes Cancer       Date:  2019-01-29       Impact factor: 5.006

3.  Canine urothelial carcinoma: genomically aberrant and comparatively relevant.

Authors:  S G Shapiro; S Raghunath; C Williams; A A Motsinger-Reif; J M Cullen; T Liu; D Albertson; M Ruvolo; A Bergstrom Lucas; J Jin; D W Knapp; J D Schiffman; M Breen
Journal:  Chromosome Res       Date:  2015-03-18       Impact factor: 5.239

4.  Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.

Authors:  Daniel L Kiss; Catherine E Waters; Iman M Ouda; Joshua C Saldivar; Jenna R Karras; Zaynab A Amin; Seham Mahrous; Teresa Druck; Ralf A Bundschuh; Daniel R Schoenberg; Kay Huebner
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-14       Impact factor: 4.490

5.  Human CST Facilitates Genome-wide RAD51 Recruitment to GC-Rich Repetitive Sequences in Response to Replication Stress.

Authors:  Megan Chastain; Qing Zhou; Olga Shiva; Maria Fadri-Moskwik; Leanne Whitmore; Pingping Jia; Xueyu Dai; Chenhui Huang; Ping Ye; Weihang Chai
Journal:  Cell Rep       Date:  2016-08-02       Impact factor: 9.423

6.  WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.

Authors:  Mohammad Abu-Odeh; Zaidoun Salah; Christoph Herbel; Thomas G Hofmann; Rami I Aqeilan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

7.  Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.

Authors:  Morgan S Schrock; Jenna R Karras; Matthew J Guggenbiller; Teresa Druck; Bahadir Batar; Kay Huebner
Journal:  Adv Biol Regul       Date:  2016-09-26

Review 8.  WWOX: a fragile tumor suppressor.

Authors:  Morgan S Schrock; Kay Huebner
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-22

Review 9.  Fragility Extraordinaire: Unsolved Mysteries of Chromosome Fragile Sites.

Authors:  Wenyi Feng; Arijita Chakraborty
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 10.  WWOX, large common fragile site genes, and cancer.

Authors:  Ge Gao; David I Smith
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.